We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

2 hedge funds and large institutions have $442 invested in Avadel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 202 closing their positions.

New
Increased
Maintained
Reduced
Closed

75.53% less ownership

Funds ownership: 75.53% → 0% (-76%)

99% less funds holding

Funds holding: 207 → 2 (-205)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.6B → $442 (-$1.6B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 202

Holders
2
Holders Change
-205
Holders Change %
-99.03%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
202
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$152M
2
GJL
Gendell Jeffrey L
-$103M
3
WAM
Weiss Asset Management
Massachusetts
-$97.3M
4
TAL
TIG Advisors LLC
New York
-$83.2M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$64.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
151
Russell Investments Group
United Kingdom
– -$272K -12,625 Closed
Canada Pension Plan Investment Board
152
Canada Pension Plan Investment Board
Ontario, Canada
– -$269K -12,500 Closed
EGM
153
Engineers Gate Manager
New York
– -$245K -11,357 Closed
GCM
154
Graham Capital Management
Connecticut
– -$239K -11,112 Closed
EWA
155
Exencial Wealth Advisors
Oklahoma
– -$238K -11,021 Closed
American Century Companies
156
American Century Companies
Missouri
– -$236K -10,936 Closed
Commonwealth Equity Services
157
Commonwealth Equity Services
Massachusetts
– -$236K -10,934 Closed
Rafferty Asset Management
158
Rafferty Asset Management
New York
– -$235K -10,884 Closed
OSAM
159
O'Shaughnessy Asset Management
Connecticut
– -$233K -10,817 Closed
Royal Bank of Canada
160
Royal Bank of Canada
Ontario, Canada
– -$227K -10,541 Closed
Fidelity Investments
161
Fidelity Investments
Massachusetts
– -$226K -10,489 Closed
CCM
162
Chicago Capital Management
Illinois
– -$163K -10,000 Closed
EWM
163
Edge Wealth Management
New York
– -$216K -10,000 Closed
KAS
164
Kestra Advisory Services
Texas
– -$216K -10,000 Closed
Envestnet Asset Management
165
Envestnet Asset Management
Illinois
– -$213K -9,867 Closed
HCMT
166
Highland Capital Management (Tennessee)
Tennessee
– -$213K -9,861 Closed
X
167
Xponance
Pennsylvania
– -$210K -9,763 Closed
Cetera Investment Advisers
168
Cetera Investment Advisers
Illinois
– -$208K -9,673 Closed
PCM
169
PenderFund Capital Management
British Columbia, Canada
– -$172K -8,004 Closed
AAM
170
Advisors Asset Management
Colorado
– -$160K -7,441 Closed
SOADOR
171
State of Alaska Department of Revenue
Alaska
– -$121K -5,656 Closed
LFG
172
Larson Financial Group
Missouri
– -$86.9K -4,034 Closed
SWM
173
SHP Wealth Management
Massachusetts
– -$70K -3,250 Closed
AB
174
Amalgamated Bank
New York
– -$60K -2,807 Closed
Carson Wealth (CWM LLC)
175
Carson Wealth (CWM LLC)
Nebraska
– -$55K -2,550 Closed
5 6
7
8 9

AVDL Hedge Fund Activity: Q1 2026 in Review

2 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2026, worth a combined $442 — down 100% from $1.6B a quarter earlier.

Sellers outnumbered buyers: 202 funds closed out of AVDL and 0 opened new positions — a net loss of 202 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $152M sold.

  • 2 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2026, down from 207 in Q4 2025.
  • Funds reported $442 of Avadel Pharmaceuticals stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avadel Pharmaceuticals positions in Q1 2026 and 202 closed out, a net change of -202 holders.
  • The largest Avadel Pharmaceuticals seller in Q1 2026 was BlackRock, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2026.